142 related articles for article (PubMed ID: 27166757)
1. Multiparameter analysis of naevi and primary melanomas identifies a subset of naevi with elevated markers of transformation.
Fox C; Lambie D; Wilmott JS; Pinder A; Pavey S; Lê Cao KA; Akalin T; Karaarslan IK; Ozdemir F; Scolyer RA; Yamada M; Soyer HP; Schaider H; Gabrielli B
Pigment Cell Melanoma Res; 2016 Jul; 29(4):444-52. PubMed ID: 27166757
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
[TBL] [Abstract][Full Text] [Related]
3. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
4. Melanoma with benign melanocytic naevus components: reappraisal of clinicopathological features and prognosis.
Kaddu S; Smolle J; Zenahlik P; Hofmann-Wellenhof R; Kerl H
Melanoma Res; 2002 Jun; 12(3):271-8. PubMed ID: 12140384
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
6. Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues.
Hussein MR
J Clin Pathol; 2005 May; 58(5):453-6. PubMed ID: 15858113
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of proliferation indices and ploidy in dysplastic naevi and malignant melanomas using flow cytometry.
Slater SD; Cook MG; Fisher C; Wright NA; Foster CS
Histopathology; 1991 Oct; 19(4):337-44. PubMed ID: 1937413
[TBL] [Abstract][Full Text] [Related]
8. The melanoma-specific XMEL antigen is expressed in dysplastic naevi.
Tron VA; Crawford R; Vielkind JR
Melanoma Res; 1997 Jun; 7(3):209-13. PubMed ID: 9195559
[TBL] [Abstract][Full Text] [Related]
9. Linear discriminant analysis of dermoscopic parameters for the differentiation of early melanomas from Clark naevi.
Oka H; Tanaka M; Kobayashi S; Argenziano G; Soyer HP; Nishikawa T
Melanoma Res; 2004 Apr; 14(2):131-4. PubMed ID: 15057043
[TBL] [Abstract][Full Text] [Related]
10. Prepubertal melanoma in a medium-sized congenital naevus.
De Raeve L; Danau W; De Backer A; Otten J
Eur J Pediatr; 1993 Sep; 152(9):734-6. PubMed ID: 8223803
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of monoclonal antibody HMB45 in the histopathologic diagnosis of melanoma].
Pluot M; Joundi A; Grosshans E
Ann Dermatol Venereol; 1990; 117(10):691-9. PubMed ID: 1705764
[TBL] [Abstract][Full Text] [Related]
12. The distribution of melanocytic naevi in melanoma patients and control subjects.
Kelly JW; Holly EA; Shpall SN; Ahn DK
Australas J Dermatol; 1989; 30(1):1-8. PubMed ID: 2486046
[TBL] [Abstract][Full Text] [Related]
13. VEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas.
Pisacane AM; Risio M
Melanoma Res; 2005 Feb; 15(1):39-43. PubMed ID: 15714119
[TBL] [Abstract][Full Text] [Related]
14. Do all melanomas come from "moles"? A study of the histological association between melanocytic naevi and melanoma.
Marks R; Dorevitch AP; Mason G
Australas J Dermatol; 1990; 31(2):77-80. PubMed ID: 2095738
[TBL] [Abstract][Full Text] [Related]
15. Cadherin expression in melanocytic naevi and malignant melanomas.
Cowley GP; Smith ME
J Pathol; 1996 Jun; 179(2):183-7. PubMed ID: 8758211
[TBL] [Abstract][Full Text] [Related]
16. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
Fröhlich E; Mack AF; Garbe C; Klessen C
Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
[TBL] [Abstract][Full Text] [Related]
17. Micro-anatomy related antigen expression in melanocytic lesions.
Meije CB; Mooi WJ; Le Poole IC; Van Muijen GN; Das PK
J Pathol; 2000 Apr; 190(5):572-8. PubMed ID: 10727983
[TBL] [Abstract][Full Text] [Related]
18. Intermediate-effect biomarkers in prevention of skin cancer.
Doré JF; Pedeux R; Boniol M; Chignol MC; Autier P
IARC Sci Publ; 2001; 154():81-91. PubMed ID: 11220671
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic naevi and melanoma: an epidemiological perspective.
Swerdlow AJ; Green A
Br J Dermatol; 1987 Aug; 117(2):137-46. PubMed ID: 3307891
[TBL] [Abstract][Full Text] [Related]
20. Melanoma inhibitor of apoptosis protein is expressed differentially in melanoma and melanocytic naevus, but similarly in primary and metastatic melanomas.
Gong J; Chen N; Zhou Q; Yang B; Wang Y; Wang X
J Clin Pathol; 2005 Oct; 58(10):1081-5. PubMed ID: 16189155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
